Eagle Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-351,164
| Closed | -$6.7M | – | 554 |
|
|
2022
Q3 | $6.7M | Sell |
351,164
-9,576
| -3% | -$183K | 0.04% | 297 |
|
|
2022
Q2 | $6.55M | Sell |
360,740
-24,383
| -6% | -$443K | 0.04% | 305 |
|
|
2022
Q1 | $9.71M | Buy |
385,123
+18,874
| +5% | +$476K | 0.05% | 276 |
|
|
2021
Q4 | $10.1M | Sell |
366,249
-14,125
| -4% | -$390K | 0.04% | 310 |
|
|
2021
Q3 | $12.3M | Buy |
380,374
+32,093
| +9% | +$1.04M | 0.06% | 275 |
|
|
2021
Q2 | $10.7M | Buy |
+348,281
| New | +$10.7M | 0.05% | 315 |
|